FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to chemical-pharmaceutical industry and deals with composition, which contains salt of "п"-tolyolsulfonic acid of methylamide 4 {4-[3 -(4-chlor-3-tri-fluoromethylphenyl)-ureido]-phenoxypyridin-2-carbonic acid as active substance in amount not less than 55% of composition weight, and at least one pharmaceutically acceptable carrier. Invention also relates to application of said composition for treatment of hyperproliferative diseases such as cancer.
EFFECT: composition possesses high stability in storing, and possesses high bioaccessability.
16 cl, 2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIARYLCARBAMIDE FOR TREATING PULMONARY HYPERTENSION | 2006 |
|
RU2431484C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING PRODRUG OF HCV POLYMERASE INHIBITOR | 2010 |
|
RU2489153C2 |
| USE OF 3-(4-AMINO-1-OXO-1, 3-DIHYDROISOINDOL-2-YL)PIPERIDINE-2,6-DIONE FOR TREATING MANTLE CELL LYMPHOMAS | 2007 |
|
RU2446804C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING ARTERIAL HYPERTENSION AND CONGESTIVE CARDIAC FAILURE AND METHOD FOR PREPARING IT | 2011 |
|
RU2479310C2 |
| COMBINATION THERAPY FOR TREATMENT OF MAMMARY GLAND CANCER | 2018 |
|
RU2764724C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING QUINOLINE DERIVATIVE | 2010 |
|
RU2548673C2 |
| NEW PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2779429C2 |
| STABLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING LEVOCETIRIZINE, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND MONTELUKAST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2013 |
|
RU2614382C2 |
| SOLID DISPERSIONS | 2016 |
|
RU2694832C2 |
| SALTS OF 4-((2-(6-(4-METHYLPIPERAZINE-1-CARBONYL)-NAPHTHALEN-2-YL)ETHYL) AMINO)QUINAZOLINE-6-CARBONITRILE AND PHARMACEUTICAL COMPOSITION | 2017 |
|
RU2641001C1 |
